While in peripheral blood mononuclear cells of secondary progressive MS patients, MTX was reported to not seemly influence the production of inflammatory mediators, IL-6, IL-12p40, IL-10, and TGF-β [66], our data shows other results in the heart. Here, IL6 is linked to myeloid sarcoma.